Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

BIT:ICOS - Borsa Italiana Milan - IT0005455875 - Common Stock - Currency: EUR

13.24  -0.18 (-1.34%)

Fundamental Rating

4

Overall ICOS gets a fundamental rating of 4 out of 10. We evaluated ICOS against 12 industry peers in the Personal Care Products industry. ICOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ICOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ICOS was profitable.
ICOS had a positive operating cash flow in the past year.
In the past 5 years ICOS has always been profitable.
ICOS had a positive operating cash flow in each of the past 5 years.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

1.2 Ratios

ICOS has a Return On Assets (4.47%) which is in line with its industry peers.
The Return On Equity of ICOS (10.11%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 11.79%, ICOS is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICOS is below the industry average of 11.84%.
The 3 year average ROIC (9.12%) for ICOS is below the current ROIC(11.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.47%
ROE 10.11%
ROIC 11.79%
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 4.51%, ICOS is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of ICOS has declined.
With a Operating Margin value of 8.72%, ICOS is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ICOS has declined.
ICOS has a Gross Margin of 19.61%. This is amonst the worse of the industry: ICOS underperforms 91.67% of its industry peers.
ICOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.72%
PM (TTM) 4.51%
GM 19.61%
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 5 10 15 20

6

2. Health

2.1 Basic Checks

ICOS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ICOS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICOS has more shares outstanding
ICOS has a better debt/assets ratio than last year.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

ICOS has an Altman-Z score of 3.16. This indicates that ICOS is financially healthy and has little risk of bankruptcy at the moment.
ICOS has a Altman-Z score of 3.16. This is comparable to the rest of the industry: ICOS outperforms 58.33% of its industry peers.
The Debt to FCF ratio of ICOS is 1.25, which is an excellent value as it means it would take ICOS, only 1.25 years of fcf income to pay off all of its debts.
ICOS has a Debt to FCF ratio of 1.25. This is amongst the best in the industry. ICOS outperforms 91.67% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that ICOS is not too dependend on debt financing.
ICOS's Debt to Equity ratio of 0.10 is amongst the best of the industry. ICOS outperforms 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.25
Altman-Z 3.16
ROIC/WACC1.61
WACC7.33%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.10 indicates that ICOS should not have too much problems paying its short term obligations.
ICOS has a Current ratio (1.10) which is comparable to the rest of the industry.
ICOS has a Quick Ratio of 1.10. This is a bad value and indicates that ICOS is not financially healthy enough and could expect problems in meeting its short term obligations.
ICOS has a Quick ratio (0.66) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.66
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

ICOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.53%.
ICOS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.17% yearly.
ICOS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.57%.
The Revenue has been growing slightly by 7.40% on average over the past years.
EPS 1Y (TTM)-12.53%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.97%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%

3.2 Future

Based on estimates for the next years, ICOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.90% on average per year.
ICOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.50% yearly.
EPS Next Y5.28%
EPS Next 2Y12.01%
EPS Next 3Y12.87%
EPS Next 5Y11.9%
Revenue Next Year7.36%
Revenue Next 2Y7.71%
Revenue Next 3Y7.39%
Revenue Next 5Y2.5%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.17, the valuation of ICOS can be described as expensive.
Based on the Price/Earnings ratio, ICOS is valued a bit more expensive than 75.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of ICOS to the average of the S&P500 Index (28.47), we can say ICOS is valued inline with the index average.
With a Price/Forward Earnings ratio of 17.44, ICOS is valued on the expensive side.
ICOS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ICOS is cheaper than 75.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 92.74. ICOS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 28.17
Fwd PE 17.44
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

ICOS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICOS is cheaper than 83.33% of the companies in the same industry.
ICOS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.75
EV/EBITDA 9.03
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICOS does not grow enough to justify the current Price/Earnings ratio.
ICOS's earnings are expected to grow with 12.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.34
PEG (5Y)24.18
EPS Next 2Y12.01%
EPS Next 3Y12.87%

2

5. Dividend

5.1 Amount

ICOS has a Yearly Dividend Yield of 1.34%.
Compared to an average industry Dividend Yield of 2.13, ICOS is paying slightly less dividend.
With a Dividend Yield of 1.34, ICOS pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.34%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

42.88% of the earnings are spent on dividend by ICOS. This is a bit on the high side, but may be sustainable.
DP42.88%
EPS Next 2Y12.01%
EPS Next 3Y12.87%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

INTERCOS SPA

BIT:ICOS (2/5/2025, 11:36:26 AM)

13.24

-0.18 (-1.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-06 2024-11-06
Earnings (Next)N/A N/A
Inst Owners42.11%
Inst Owner ChangeN/A
Ins Owners32.2%
Ins Owner ChangeN/A
Market Cap1.27B
Analysts84.62
Price Target18.19 (37.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.34%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP42.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.27%
PT rev (3m)-4.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-8.23%
EPS NY rev (3m)-8.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 28.17
Fwd PE 17.44
P/S 1.27
P/FCF 29.75
P/OCF 13.39
P/B 2.86
P/tB 4.99
EV/EBITDA 9.03
EPS(TTM)0.47
EY3.55%
EPS(NY)0.76
Fwd EY5.74%
FCF(TTM)0.45
FCFY3.36%
OCF(TTM)0.99
OCFY7.47%
SpS10.39
BVpS4.64
TBVpS2.65
PEG (NY)5.34
PEG (5Y)24.18
Profitability
Industry RankSector Rank
ROA 4.47%
ROE 10.11%
ROCE 16.85%
ROIC 11.79%
ROICexc 15.93%
ROICexgc 31.75%
OM 8.72%
PM (TTM) 4.51%
GM 19.61%
FCFM 4.29%
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
ROICexc(3y)13.17%
ROICexc(5y)13.68%
ROICexgc(3y)24.59%
ROICexgc(5y)25.8%
ROCE(3y)13.03%
ROCE(5y)13.69%
ROICexcg growth 3Y24.46%
ROICexcg growth 5Y11.44%
ROICexc growth 3Y21.76%
ROICexc growth 5Y5.26%
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.25
Debt/EBITDA 0.34
Cap/Depr 112.13%
Cap/Sales 5.23%
Interest Coverage 18.71
Cash Conversion 71.1%
Profit Quality 94.94%
Current Ratio 1.1
Quick Ratio 0.66
Altman-Z 3.16
F-Score5
WACC7.33%
ROIC/WACC1.61
Cap/Depr(3y)108.68%
Cap/Depr(5y)109.85%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.96%
Profit Quality(3y)82.87%
Profit Quality(5y)94.39%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.53%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.97%
EPS Next Y5.28%
EPS Next 2Y12.01%
EPS Next 3Y12.87%
EPS Next 5Y11.9%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%
Revenue Next Year7.36%
Revenue Next 2Y7.71%
Revenue Next 3Y7.39%
Revenue Next 5Y2.5%
EBIT growth 1Y-7.51%
EBIT growth 3Y23.97%
EBIT growth 5Y4.76%
EBIT Next Year62.05%
EBIT Next 3Y26.8%
EBIT Next 5Y21.32%
FCF growth 1Y4150.5%
FCF growth 3Y-1.18%
FCF growth 5Y1.22%
OCF growth 1Y134.98%
OCF growth 3Y4.1%
OCF growth 5Y4.57%